User menu

ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: one-year safety and efficacy evaluation.

Bibliographic reference Laterre, Pierre-François ; Abraham, Edward ; Janes, Jonathan M ; Trzaskoma, Benjamin ; Correll, Nancy L ; et. al. ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: one-year safety and efficacy evaluation.. In: Critical care medicine, Vol. 35, no. 6, p. 1457-63 (2007)
Permanent URL http://hdl.handle.net/2078.1/26304